Query 042006
Match_columns 119
No_of_seqs 110 out of 424
Neff 3.9
Searched_HMMs 46136
Date Fri Mar 29 13:01:09 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/042006.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/042006hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 cd04706 PLA2_plant PLA2_plant: 100.0 4.6E-40 9.9E-45 241.5 6.5 110 4-113 2-115 (117)
2 KOG4087 Phospholipase A2 [Lipi 99.8 5.6E-21 1.2E-25 144.9 -1.3 57 19-81 38-94 (144)
3 cd00125 PLA2c PLA2c: Phospholi 99.8 3.8E-20 8.3E-25 134.9 -1.3 63 13-81 11-73 (115)
4 cd04707 otoconin_90 otoconin_9 99.7 4.1E-19 8.8E-24 130.3 -1.7 61 13-80 8-70 (117)
5 smart00085 PA2c Phospholipase 99.7 6.6E-18 1.4E-22 122.7 -0.6 62 13-80 11-73 (117)
6 cd00618 PLA2_like PLA2_like: P 99.6 2.1E-16 4.5E-21 106.0 3.2 39 23-61 1-39 (83)
7 PF00068 Phospholip_A2_1: Phos 99.4 3.5E-15 7.5E-20 107.7 -3.0 53 21-79 20-72 (116)
8 cd04704 PLA2_bee_venom_like PL 98.5 5.4E-08 1.2E-12 69.3 3.0 50 27-79 7-76 (97)
9 PF05826 Phospholip_A2_2: Phos 97.7 1.4E-05 3E-10 56.9 1.0 51 27-78 6-74 (99)
10 PF08398 Parvo_coat_N: Parvovi 96.8 0.0003 6.4E-09 47.6 -0.2 41 27-70 5-45 (64)
11 cd04705 PLA2_group_III_like PL 95.8 0.0053 1.2E-07 44.4 1.9 36 43-78 32-82 (100)
12 PF06951 PLA2G12: Group XII se 95.3 0.017 3.7E-07 45.7 3.1 71 6-80 55-133 (184)
13 PF09402 MSC: Man1-Src1p-C-ter 27.5 20 0.00044 29.1 0.0 45 49-97 55-99 (334)
14 PF07420 DUF1509: Protein of u 26.6 27 0.00058 30.5 0.5 10 44-53 75-84 (377)
15 smart00181 EGF Epidermal growt 25.1 49 0.0011 17.7 1.3 19 17-35 12-30 (35)
16 PF01822 WSC: WSC domain; Int 23.0 19 0.00042 22.4 -0.7 31 5-35 26-58 (82)
17 KOG1214 Nidogen and related ba 22.6 32 0.00068 34.1 0.3 46 23-70 807-856 (1289)
18 PF11405 Inhibitor_I67: Bromel 22.0 38 0.00082 20.9 0.5 16 24-39 2-17 (41)
No 1
>cd04706 PLA2_plant PLA2_plant: Plant-specific sub-family of Phospholipase A2, a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. Enzymatically active PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids; secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis cannot form bilayers leading to a change in membrane conformation and ultimately to a block in the release of neurotransmitters. PLA2 may form dimers or oligomers. This sub-family does not appear to have a conserved active site and metal-binding loop.
Probab=100.00 E-value=4.6e-40 Score=241.52 Aligned_cols=110 Identities=40% Similarity=0.838 Sum_probs=103.4
Q ss_pred CCCccccccccccccccc-cCCCcccccCCCCCCCCCCCcchhhhhhhhcCccccc--CCCccCCChHHHHHHHHHHhhc
Q 042006 4 DSQVKCSRTCVAENCNSV-GIRYRKYCRVGWSDCHGEKPCDDLDACCKIHDECVDK--KGLTNIKCHEKFKRCIKKVQKS 80 (119)
Q Consensus 4 ~~~~~csr~C~s~~C~~~-~~~YGcYCG~GgsGcpg~~PiD~lD~CC~~HD~CY~~--~~~~~~~C~p~~~~y~~~~~~~ 80 (119)
+.++.||||||+++|+.| |.+||||||+|++|+||+.|+|+||+||+.||+||++ .++.+++|+.+|.+|+.++.++
T Consensus 2 ~~~~~csrtc~~~~c~~~~y~~YG~yCG~g~~g~~~~~P~D~lD~CC~~HD~Cy~~~~~~~~~c~C~~~f~~Cl~~~~~~ 81 (117)
T cd04706 2 SVPEECSRTCESYFCSGPPFLRYGKYCGPGYSGCPGERPCDDLDACCMTHDACVQAKKNDYLSLECNEKFKNCVRRFRKA 81 (117)
T ss_pred CccccccccchhhhccCCcccccCcccCCCCCCCCCCCCcchhhHHHHhCcCcccCCCCCcCCchHHHHHHHHHHHhccc
Confidence 578999999999999988 9999999999999999999999999999999999998 6788999999999999999998
Q ss_pred CCCCC-CCCCCCcchhhHHHHHHHHHHHHHHHHH
Q 042006 81 GNVGF-SYKCPYDTVVPTMVQGMDMAILLRANLV 113 (119)
Q Consensus 81 g~~~f-~~~C~~~~~~~~~~~~m~~a~~~~~~~~ 113 (119)
+..+| +++|++++++|||..+||+|||||+|++
T Consensus 82 ~~~~~~~~~C~~~~v~~~i~~~~~~a~~~~~~~~ 115 (117)
T cd04706 82 RKPTFEGNKCIVTFVIPVITVVMDAALIASKLGK 115 (117)
T ss_pred ccceeccccCccceeeeeeecchHHHHHHHHhcc
Confidence 55555 6799999999999999999999999986
No 2
>KOG4087 consensus Phospholipase A2 [Lipid transport and metabolism]
Probab=99.79 E-value=5.6e-21 Score=144.89 Aligned_cols=57 Identities=28% Similarity=0.504 Sum_probs=52.3
Q ss_pred ccccCCCcccccCCCCCCCCCCCcchhhhhhhhcCcccccCCCccCCChHHHHHHHHHHhhcC
Q 042006 19 NSVGIRYRKYCRVGWSDCHGEKPCDDLDACCKIHDECVDKKGLTNIKCHEKFKRCIKKVQKSG 81 (119)
Q Consensus 19 ~~~~~~YGcYCG~GgsGcpg~~PiD~lD~CC~~HD~CY~~~~~~~~~C~p~~~~y~~~~~~~g 81 (119)
.+.|++||||||+|||| +|+|+|||||+.||+||++++.. +|+|++.+|+|+++++.
T Consensus 38 ~l~Y~~YGCyCGlGG~G----~P~D~iDwCC~~HDcCY~~le~~--gC~py~~~Ys~sc~n~~ 94 (144)
T KOG4087|consen 38 ALSYNKYGCYCGLGGSG----QPKDAIDWCCHAHDCCYDRLEEK--GCSPYTERYSWSCSNQS 94 (144)
T ss_pred cceecCccccccCCCCC----CccchHHHHHhcccHHHHHHHHc--CCCccccceeeEeeCCe
Confidence 34499999999999999 99999999999999999998754 89999999999999873
No 3
>cd00125 PLA2c PLA2c: Phospholipase A2, a family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids (PC or phosphatidylethanolamine), usually in a metal-dependent reaction, to generate lysophospholipid (LysoPL) and a free fatty acid (FA). The resulting products are either dietary or used in synthetic pathways for leukotrienes and prostaglandins. Often, arachidonic acid is released as a free fatty acid and acts as second messenger in signaling networks. Secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis (LysoPL and FA) cannot form bilayers leading to a change in membrane conformation and ultimately to a block in
Probab=99.76 E-value=3.8e-20 Score=134.89 Aligned_cols=63 Identities=29% Similarity=0.564 Sum_probs=53.9
Q ss_pred ccccccccccCCCcccccCCCCCCCCCCCcchhhhhhhhcCcccccCCCccCCChHHHHHHHHHHhhcC
Q 042006 13 CVAENCNSVGIRYRKYCRVGWSDCHGEKPCDDLDACCKIHDECVDKKGLTNIKCHEKFKRCIKKVQKSG 81 (119)
Q Consensus 13 C~s~~C~~~~~~YGcYCG~GgsGcpg~~PiD~lD~CC~~HD~CY~~~~~~~~~C~p~~~~y~~~~~~~g 81 (119)
|++....+.|.+||||||+||+| +|||+|||||+.||+||+++... +|+|++..|.+.+.++.
T Consensus 11 c~tgr~~~~Y~~YGCyCG~GG~G----~PvD~~DrCC~~HD~CY~~~~~~--~C~p~~~~Y~y~~~~~~ 73 (115)
T cd00125 11 CTTGRSALDYNGYGCYCGLGGSG----TPVDDTDRCCQVHDCCYDRAEKG--GCSPYFTSYSYTCSDGQ 73 (115)
T ss_pred HhcCCCHHHHhhcCCccCCCCCC----CCcccHHHHHHHHHhHHhccccC--CCccccccceEEEECCc
Confidence 44444445689999999999999 99999999999999999998653 79999999999987553
No 4
>cd04707 otoconin_90 otoconin_90: Phospholipase A2-like domains present in otoconin-90 and otoconin-95, mammal proteins that are principal matrix proteins of calcitic otoconia. Interactions involving otoconin-90 may trigger or constitute key events in otoconia formation. The PLA2-like domains in otoconins may have lost their metal-binding sites.
Probab=99.71 E-value=4.1e-19 Score=130.26 Aligned_cols=61 Identities=25% Similarity=0.496 Sum_probs=48.7
Q ss_pred ccccccccccCCCcccccCCCCCCCCCCCcchhhhhhhhcCcccccCCCccCCChH--HHHHHHHHHhhc
Q 042006 13 CVAENCNSVGIRYRKYCRVGWSDCHGEKPCDDLDACCKIHDECVDKKGLTNIKCHE--KFKRCIKKVQKS 80 (119)
Q Consensus 13 C~s~~C~~~~~~YGcYCG~GgsGcpg~~PiD~lD~CC~~HD~CY~~~~~~~~~C~p--~~~~y~~~~~~~ 80 (119)
|++....+.|.+||||||+||+| +|||+|||||+.||+||+++... +|.| + ..|.|++.++
T Consensus 8 c~tgr~~~~Y~~YGCyCG~GG~G----~PvD~~DrCC~~HD~CY~~~~~~--~C~~~~~-~~Y~y~c~~~ 70 (117)
T cd04707 8 CLTGRCPREFEDYGCYCGQEGEG----LPVDELDRCCFQHRCCLEQASEM--GCLQDRK-LSTEVTCVDH 70 (117)
T ss_pred hhcCCCHHHHcccCCcccCCCCC----CCcccchhHHHHhHHHHhhhhhc--CCCCCCC-cceEEEEECC
Confidence 44434444599999999999999 99999999999999999998653 6854 4 5777777654
No 5
>smart00085 PA2c Phospholipase A2.
Probab=99.66 E-value=6.6e-18 Score=122.69 Aligned_cols=62 Identities=27% Similarity=0.479 Sum_probs=51.8
Q ss_pred ccccccc-cccCCCcccccCCCCCCCCCCCcchhhhhhhhcCcccccCCCccCCChHHHHHHHHHHhhc
Q 042006 13 CVAENCN-SVGIRYRKYCRVGWSDCHGEKPCDDLDACCKIHDECVDKKGLTNIKCHEKFKRCIKKVQKS 80 (119)
Q Consensus 13 C~s~~C~-~~~~~YGcYCG~GgsGcpg~~PiD~lD~CC~~HD~CY~~~~~~~~~C~p~~~~y~~~~~~~ 80 (119)
|++.... +.|..||||||+|++| +|+|+|||||+.||.||+++.. . +|+|++..|.+++.++
T Consensus 11 c~t~~~~~~~y~~YGCyCG~gg~G----~pvD~~D~CC~~HD~Cy~~~~~-~-~C~~~~~~y~~~c~~~ 73 (117)
T smart00085 11 CATGKRAWLSYGDYGCYCGWGGSG----TPVDATDRCCFVHDCCYGKAEK-E-GCNPKTTTYSYSCDNG 73 (117)
T ss_pred HhcCCCcccchhccCcccCCCCCC----CccccccchhhhcCchhhhccc-C-CCcccccceEEEEECC
Confidence 4444333 3388999999999999 9999999999999999998765 2 8999999999888754
No 6
>cd00618 PLA2_like PLA2_like: Phospholipase A2, a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids (PC or phosphatidylethanolamine), usually in a metal-dependent reaction, to generate lysophospholipid (LysoPL) and a free fatty acid (FA). The resulting products are either dietary or used in synthetic pathways for leukotrienes and prostaglandins. Often, arachidonic acid is released as a free fatty acid and acts as second messenger in signaling networks. Secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis (LysoPL and FA) cannot form bilayers leading to a change in membrane conformation and ultimately
Probab=99.62 E-value=2.1e-16 Score=105.96 Aligned_cols=39 Identities=38% Similarity=0.841 Sum_probs=35.2
Q ss_pred CCCcccccCCCCCCCCCCCcchhhhhhhhcCcccccCCC
Q 042006 23 IRYRKYCRVGWSDCHGEKPCDDLDACCKIHDECVDKKGL 61 (119)
Q Consensus 23 ~~YGcYCG~GgsGcpg~~PiD~lD~CC~~HD~CY~~~~~ 61 (119)
+.||||||+|+++++++.|+|+|||||+.||.||+....
T Consensus 1 ~~ygc~CG~g~~~~~~g~p~D~~D~CC~~HD~Cy~~~~~ 39 (83)
T cd00618 1 LPYGCYCGPGGSACPSGQPVDETDRCCRKHDCCYDQISD 39 (83)
T ss_pred CCcCcccCCCCcCCCCCCCCCcchhhhhhCccHhhhhhc
Confidence 479999999999777779999999999999999998653
No 7
>PF00068 Phospholip_A2_1: Phospholipase A2; InterPro: IPR001211 Phospholipase A2 (3.1.1.4 from EC) (PLA2) is a small lipolytic enzyme that releases fatty acids from the second carbon group of glycerol. It is involved in a number of physiologically important cellular processes, such as the liberation of arachidonic acid from membrane phospholipids []. It plays a pivotal role in the biosynthesis of prostaglandin and other mediators of inflammation. PLA2 has four to seven disulphide bonds and binds a calcium ion that is essential for activity. Within the active enzyme, the alpha amino group is involved in a conserved hydrogen-bonding network linking the N-terminal region to the active site. The side chains of two conserved residues, His and Asp, participate in the catalytic network. Many PLA2's are widely distributed in snakes, lizards, bees and mammals. In mammals there are at least four forms: pancreatic, membrane-associated as well as two less well characterised forms. The venom of most snakes contains multiple forms of PLA2. Some of them are presynaptic neurotoxins which inhibit neuromuscular transmission by blocking acetylcholine release from the nerve termini. Some of the proteins in this family are allergens. Allergies are hypersensitivity reactions of the immune system to specific substances called allergens (such as pollen, stings, drugs, or food) that, in most people, result in no symptoms. A nomenclature system has been established for antigens (allergens) that cause IgE-mediated atopic allergies in humans [WHO/IUIS Allergen Nomenclature Subcommittee King T.P., Hoffmann D., Loewenstein H., Marsh D.G., Platts-Mills T.A.E., Thomas W. Bull. World Health Organ. 72:797-806(1994)]. This nomenclature system is defined by a designation that is composed of the first three letters of the genus; a space; the first letter of the species name; a space and an arabic number. In the event that two species names have identical designations, they are discriminated from one another by adding one or more letters (as necessary) to each species designation. The allergens in this family include allergens with the following designations: Api m 1.; GO: 0004623 phospholipase A2 activity, 0005509 calcium ion binding, 0016042 lipid catabolic process; PDB: 1OQS_F 1S6B_B 1XXW_B 1MH2_B 2RD4_B 1OZ6_A 2OSN_A 2PH4_B 1FDK_A 2BP2_A ....
Probab=99.44 E-value=3.5e-15 Score=107.73 Aligned_cols=53 Identities=26% Similarity=0.576 Sum_probs=44.9
Q ss_pred ccCCCcccccCCCCCCCCCCCcchhhhhhhhcCcccccCCCccCCChHHHHHHHHHHhh
Q 042006 21 VGIRYRKYCRVGWSDCHGEKPCDDLDACCKIHDECVDKKGLTNIKCHEKFKRCIKKVQK 79 (119)
Q Consensus 21 ~~~~YGcYCG~GgsGcpg~~PiD~lD~CC~~HD~CY~~~~~~~~~C~p~~~~y~~~~~~ 79 (119)
.|.+||||||.||+| .|||+||+||+.|+.||..+... .|+|.+..|.+.+..
T Consensus 20 ~y~~YGCyCg~~g~G----~PvD~iD~~C~~h~~Cy~~~~~~--~C~~~~~~Y~~~~~~ 72 (116)
T PF00068_consen 20 KYNDYGCYCGFGGKG----QPVDEIDRCCRKHDQCYKCAKEK--GCDPYFTSYSYSCSN 72 (116)
T ss_dssp HHSSBTTTBSSSSSS----S-SSHHHHHHHHHHHHHHHHTTT--TSSTTTSS-EEEEET
T ss_pred HHccccccCCCCCCC----CCcccccchhHHhHHHHHHHhcc--cccccccceEEEEec
Confidence 389999999999999 99999999999999999997653 799998888776643
No 8
>cd04704 PLA2_bee_venom_like PLA2_bee_venom_like: A sub-family of Phospholipase A2, similar to bee venom PLA2. PLA2 is a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. Enzymatically active PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids; secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis cannot form bilayers leading to a change in membrane conformation and ultimately to a block in the release of neurotransmitters. PLA2 may form dimers or oligomers. Bee venom PLA2 has fewer conserved disulfide bridges than most canonical PLA2s.
Probab=98.54 E-value=5.4e-08 Score=69.32 Aligned_cols=50 Identities=30% Similarity=0.761 Sum_probs=40.6
Q ss_pred ccccCCCCCCCCCCCc-----chhhhhhhhcCcccccCC---------------CccCCChHHHHHHHHHHhh
Q 042006 27 KYCRVGWSDCHGEKPC-----DDLDACCKIHDECVDKKG---------------LTNIKCHEKFKRCIKKVQK 79 (119)
Q Consensus 27 cYCG~GgsGcpg~~Pi-----D~lD~CC~~HD~CY~~~~---------------~~~~~C~p~~~~y~~~~~~ 79 (119)
.|||+|... +.+- .++|+||+.||.|++... +.++.|+.+|.+||.+..+
T Consensus 7 kWCG~Gn~a---~~~~dlG~~~~tD~CCr~HD~C~~~i~~~~~kyg~~N~~~~t~~~C~CD~~f~~CL~~~~~ 76 (97)
T cd04704 7 KWCGPGNIA---TNYSDLGAFRETDKCCREHDHCPDIISAGEYKYGLTNTRLFTRSHCDCDNRFRQCLKNVND 76 (97)
T ss_pred eecCCCCCC---CCcccccCccccchHHHccccCcCcccccccccCccCCCccccccCcHHHHHHHHHHHcCC
Confidence 699999988 2344 689999999999998631 2567999999999998754
No 9
>PF05826 Phospholip_A2_2: Phospholipase A2; InterPro: IPR001211 Phospholipase A2 (3.1.1.4 from EC) (PLA2) is a small lipolytic enzyme that releases fatty acids from the second carbon group of glycerol. It is involved in a number of physiologically important cellular processes, such as the liberation of arachidonic acid from membrane phospholipids []. It plays a pivotal role in the biosynthesis of prostaglandin and other mediators of inflammation. PLA2 has four to seven disulphide bonds and binds a calcium ion that is essential for activity. Within the active enzyme, the alpha amino group is involved in a conserved hydrogen-bonding network linking the N-terminal region to the active site. The side chains of two conserved residues, His and Asp, participate in the catalytic network. Many PLA2's are widely distributed in snakes, lizards, bees and mammals. In mammals there are at least four forms: pancreatic, membrane-associated as well as two less well characterised forms. The venom of most snakes contains multiple forms of PLA2. Some of them are presynaptic neurotoxins which inhibit neuromuscular transmission by blocking acetylcholine release from the nerve termini. Some of the proteins in this family are allergens. Allergies are hypersensitivity reactions of the immune system to specific substances called allergens (such as pollen, stings, drugs, or food) that, in most people, result in no symptoms. A nomenclature system has been established for antigens (allergens) that cause IgE-mediated atopic allergies in humans [WHO/IUIS Allergen Nomenclature Subcommittee King T.P., Hoffmann D., Loewenstein H., Marsh D.G., Platts-Mills T.A.E., Thomas W. Bull. World Health Organ. 72:797-806(1994)]. This nomenclature system is defined by a designation that is composed of the first three letters of the genus; a space; the first letter of the species name; a space and an arabic number. In the event that two species names have identical designations, they are discriminated from one another by adding one or more letters (as necessary) to each species designation. The allergens in this family include allergens with the following designations: Api m 1.; GO: 0004623 phospholipase A2 activity, 0005509 calcium ion binding, 0016042 lipid catabolic process; PDB: 1POC_A.
Probab=97.68 E-value=1.4e-05 Score=56.92 Aligned_cols=51 Identities=31% Similarity=0.744 Sum_probs=35.0
Q ss_pred ccccCCCCCCCCCC---CcchhhhhhhhcCcccccCC---------------CccCCChHHHHHHHHHHh
Q 042006 27 KYCRVGWSDCHGEK---PCDDLDACCKIHDECVDKKG---------------LTNIKCHEKFKRCIKKVQ 78 (119)
Q Consensus 27 cYCG~GgsGcpg~~---PiD~lD~CC~~HD~CY~~~~---------------~~~~~C~p~~~~y~~~~~ 78 (119)
.|||+|...-. .. ---.+|+||+.||.|..... ..++.|+.+|.+||....
T Consensus 6 ~WCG~gn~a~~-~~dlG~~~~tD~CCR~HD~C~~~I~~~~~k~gl~N~~~~T~~hC~Cd~~f~~CL~~~~ 74 (99)
T PF05826_consen 6 KWCGPGNIAKN-YSDLGEFKETDRCCREHDHCPDKIPPGETKYGLHNPRPFTISHCDCDSRFYQCLKNVN 74 (99)
T ss_dssp SSSBSS---SS-TT---SSHHHHHHHHHHHT-SSEE-TT-EETTEE--SSS-EEBHHHHHHHHHHHHTS-
T ss_pred cccCCCCCccC-cccccccHHHHHHHHhhccCCCccCCCccccccccCCcCceeecCcccHHHHHHHHcC
Confidence 69999988621 11 23479999999999998632 356899999999999844
No 10
>PF08398 Parvo_coat_N: Parvovirus coat protein VP1; InterPro: IPR013607 Parvoviruses are some of the smallest viruses containing linear, non-segmented single-stranded DNA genomes, with an average genome size of 5000 nucleotides. Parvoviruses have been described that infect a wide range of invertebrates and vertebrates and are well known for causing enteric disease in mammals. Genomes contains two large ORFs: NS1 and VP1; other ORFs are found in some sub-types and different gene products can arise from splice variants and the use of different start codons []. This is the N-terminal region of the Parvovirus VP1 coat protein []; its function is not known. ; GO: 0005198 structural molecule activity, 0019028 viral capsid
Probab=96.78 E-value=0.0003 Score=47.60 Aligned_cols=41 Identities=27% Similarity=0.310 Sum_probs=32.3
Q ss_pred ccccCCCCCCCCCCCcchhhhhhhhcCcccccCCCccCCChHHH
Q 042006 27 KYCRVGWSDCHGEKPCDDLDACCKIHDECVDKKGLTNIKCHEKF 70 (119)
Q Consensus 27 cYCG~GgsGcpg~~PiD~lD~CC~~HD~CY~~~~~~~~~C~p~~ 70 (119)
+|.|||.+=-.| .|++.+|+.++.||..|++.-+. +.+|++
T Consensus 5 ~YlGPgn~l~~g-~Pv~~~D~aA~~HD~aY~~~lk~--G~NPY~ 45 (64)
T PF08398_consen 5 KYLGPGNPLDNG-EPVNPVDAAAREHDEAYDELLKH--GDNPYL 45 (64)
T ss_pred CccCCCCCcCCC-CCCCHHHHHHHHHHHHHHHHHHc--CCCCce
Confidence 689999765445 69999999999999999985322 566665
No 11
>cd04705 PLA2_group_III_like PLA2_group_III_like: A sub-family of Phospholipase A2, similar to human group III PLA2. PLA2 is a super-family of secretory and cytosolic enzymes; the latter are either Ca dependent or Ca independent. Enzymatically active PLA2 cleaves the sn-2 position of the glycerol backbone of phospholipids; secreted PLA2s have also been found to specifically bind to a variety of soluble and membrane proteins in mammals, including receptors. As a toxin, PLA2 is a potent presynaptic neurotoxin which blocks nerve terminals by binding to the nerve membrane and hydrolyzing stable membrane lipids. The products of the hydrolysis cannot form bilayers leading to a change in membrane conformation and ultimately to a block in the release of neurotransmitters. PLA2 may form dimers or oligomers.
Probab=95.84 E-value=0.0053 Score=44.39 Aligned_cols=36 Identities=22% Similarity=0.668 Sum_probs=29.7
Q ss_pred chhhhhhhhcCcccccCC---------------CccCCChHHHHHHHHHHh
Q 042006 43 DDLDACCKIHDECVDKKG---------------LTNIKCHEKFKRCIKKVQ 78 (119)
Q Consensus 43 D~lD~CC~~HD~CY~~~~---------------~~~~~C~p~~~~y~~~~~ 78 (119)
-++|+||+.||.|-.... ..++.|+..|.+||....
T Consensus 32 ~~~DrCCR~HD~Cp~~I~~~~~k~gl~N~~~~tisHCdCD~rf~~CL~~~n 82 (100)
T cd04705 32 KEPDRCCWKHKQCPGHIIPPFSSDGHHNFHLHSVSHCDCDSRLKDCLRLSS 82 (100)
T ss_pred cchhhhhhhhhcCccccCCcccccceecCCCcccccccHHHHHHHHHHHcC
Confidence 468999999999987621 267899999999999864
No 12
>PF06951 PLA2G12: Group XII secretory phospholipase A2 precursor (PLA2G12); InterPro: IPR010711 This family consists of several group XII secretory phospholipase A2 precursor (PLA2G12) (3.1.1.4 from EC) proteins. Group XII and group V PLA(2)s are thought to participate in helper T cell immune response through release of immediate second signals and generation of downstream eicosanoids [].; GO: 0004623 phospholipase A2 activity, 0005509 calcium ion binding, 0016042 lipid catabolic process, 0005576 extracellular region
Probab=95.26 E-value=0.017 Score=45.73 Aligned_cols=71 Identities=24% Similarity=0.503 Sum_probs=47.5
Q ss_pred CccccccccccccccccCCC----cccccCCCCCCCCCCCcc----hhhhhhhhcCcccccCCCccCCChHHHHHHHHHH
Q 042006 6 QVKCSRTCVAENCNSVGIRY----RKYCRVGWSDCHGEKPCD----DLDACCKIHDECVDKKGLTNIKCHEKFKRCIKKV 77 (119)
Q Consensus 6 ~~~csr~C~s~~C~~~~~~Y----GcYCG~GgsGcpg~~PiD----~lD~CC~~HD~CY~~~~~~~~~C~p~~~~y~~~~ 77 (119)
...|-=+|-.-+.-.|..+| -+=||.-.-| .++| +.=.||-.||.||+.-+..-..||..|..|++++
T Consensus 55 d~~C~y~Cp~G~~p~pr~g~k~p~~NGCGS~~~G----~~~d~~iP~~t~CCn~HDiCYdTCg~~K~~CD~~F~~CL~~~ 130 (184)
T PF06951_consen 55 DGVCQYRCPYGQKPVPRPGYKPPEPNGCGSYFLG----LQIDIGIPAMTKCCNQHDICYDTCGSSKEDCDSQFKSCLEKI 130 (184)
T ss_pred CCCceeeCCCCCCCCCCCCCCCCCCCCCCCcccC----CcccCCCCchhccchhhhhHHHccCCCHHHHHHHHHHHHHHH
Confidence 34565556665554443332 2457763344 3444 3789999999999995543348999999999998
Q ss_pred hhc
Q 042006 78 QKS 80 (119)
Q Consensus 78 ~~~ 80 (119)
=++
T Consensus 131 C~~ 133 (184)
T PF06951_consen 131 CDD 133 (184)
T ss_pred HHH
Confidence 764
No 13
>PF09402 MSC: Man1-Src1p-C-terminal domain; InterPro: IPR018996 This entry represents the Inner nuclear membrane proteins MAN1 (also known as LEM domain-containing protein 3) and LEM domain-containing protein 2 (or LEM protein 2). Emerin and MAN1 are LEM domain-containing integral membrane proteins of the vertebrate nuclear envelope []. MAN1 is an integral protein of the inner nuclear membrane which binds to chromatin associated proteins and plays a role in nuclear organisation. The C-terminal nulceoplasmic region forms a DNA binding winged helix and binds to Smad []. LEM protein 2 is an essential protein involved in chromosome segregation and cell division, probably via its interaction with lmn-1, the main component of nuclear lamina. Has some overlapping function with emr-1.; GO: 0005639 integral to nuclear inner membrane; PDB: 2CH0_A.
Probab=27.53 E-value=20 Score=29.09 Aligned_cols=45 Identities=22% Similarity=0.290 Sum_probs=0.0
Q ss_pred hhhcCcccccCCCccCCChHHHHHHHHHHhhcCCCCCCCCCCCcchhhH
Q 042006 49 CKIHDECVDKKGLTNIKCHEKFKRCIKKVQKSGNVGFSYKCPYDTVVPT 97 (119)
Q Consensus 49 C~~HD~CY~~~~~~~~~C~p~~~~y~~~~~~~g~~~f~~~C~~~~~~~~ 97 (119)
|-.|..||+.... .|++-|......+...|-.. ..+|-.|....-
T Consensus 55 CP~~a~C~~~~~~---~C~~~y~~~~~~l~~~g~~p-~~~Ci~D~~k~~ 99 (334)
T PF09402_consen 55 CPEHAICYPGLKL---ECEPGYVLKPSPLSLFGLIP-PPKCIPDTEKEE 99 (334)
T ss_dssp -------------------------------------------------
T ss_pred ccccccccccccc---cccccccccccccccccccc-cccccccHHHHH
Confidence 9999999999654 79999988876666666666 778887776443
No 14
>PF07420 DUF1509: Protein of unknown function (DUF1509); InterPro: IPR010883 This family consists of several uncharacterised viral proteins, which include LORF2 from the Marek's disease-like viruses (Meleagrid herpesvirus 1 (MeHV-1) and LORF3 from Gallid herpesvirus 2. Members of this family are typically around 400 residues in length. The function of this family is unknown.
Probab=26.58 E-value=27 Score=30.52 Aligned_cols=10 Identities=50% Similarity=1.042 Sum_probs=8.2
Q ss_pred hhhhhhhhcC
Q 042006 44 DLDACCKIHD 53 (119)
Q Consensus 44 ~lD~CC~~HD 53 (119)
=|||||+.|-
T Consensus 75 CLDWCC~Fh~ 84 (377)
T PF07420_consen 75 CLDWCCSFHP 84 (377)
T ss_pred HHHHHhccCC
Confidence 4899999873
No 15
>smart00181 EGF Epidermal growth factor-like domain.
Probab=25.05 E-value=49 Score=17.69 Aligned_cols=19 Identities=21% Similarity=0.489 Sum_probs=15.0
Q ss_pred ccccccCCCcccccCCCCC
Q 042006 17 NCNSVGIRYRKYCRVGWSD 35 (119)
Q Consensus 17 ~C~~~~~~YGcYCG~GgsG 35 (119)
.|......|=|.|..|+.|
T Consensus 12 ~C~~~~~~~~C~C~~g~~g 30 (35)
T smart00181 12 TCINTPGSYTCSCPPGYTG 30 (35)
T ss_pred EEECCCCCeEeECCCCCcc
Confidence 4655567888999999988
No 16
>PF01822 WSC: WSC domain; InterPro: IPR002889 The WSC domain is a putative carbohydrate binding domain. The domain contains up to eight conserved cysteine residues that may be involved in disulphide bridges. The Trichoderma harzianum beta-1,3 exoglucanase contains two copies of the WSC domain, while the yeast SLG1 protein contains only one.
Probab=23.00 E-value=19 Score=22.42 Aligned_cols=31 Identities=23% Similarity=0.505 Sum_probs=22.4
Q ss_pred CCccccccccccccccccCCCc--ccccCCCCC
Q 042006 5 SQVKCSRTCVAENCNSVGIRYR--KYCRVGWSD 35 (119)
Q Consensus 5 ~~~~csr~C~s~~C~~~~~~YG--cYCG~GgsG 35 (119)
..+.|.+.|.+..=.+..+.+| ||||.....
T Consensus 26 t~~~C~~~C~~~g~~~agl~~g~~C~Cg~~~~~ 58 (82)
T PF01822_consen 26 TPEKCAEHCRAKGYPYAGLENGNECYCGNSLPS 58 (82)
T ss_pred CHHHHHHhcCcCCCceEEEecCCEEEcCCccCc
Confidence 4567888898775445556778 999877555
No 17
>KOG1214 consensus Nidogen and related basement membrane protein proteins [Cell wall/membrane/envelope biogenesis; Extracellular structures]
Probab=22.58 E-value=32 Score=34.07 Aligned_cols=46 Identities=26% Similarity=0.619 Sum_probs=36.7
Q ss_pred CCCcccccCCCCCCCCCCCcchhhhh----hhhcCcccccCCCccCCChHHH
Q 042006 23 IRYRKYCRVGWSDCHGEKPCDDLDAC----CKIHDECVDKKGLTNIKCHEKF 70 (119)
Q Consensus 23 ~~YGcYCG~GgsGcpg~~PiD~lD~C----C~~HD~CY~~~~~~~~~C~p~~ 70 (119)
..|-|-|-+|++| .|-.=.|. |.| |+--..||...+.+.++|.|-+
T Consensus 807 s~y~C~CLPGfsG-DG~~c~dv-DeC~psrChp~A~CyntpgsfsC~C~pGy 856 (1289)
T KOG1214|consen 807 STYSCACLPGFSG-DGHQCTDV-DECSPSRCHPAATCYNTPGSFSCRCQPGY 856 (1289)
T ss_pred ceEEEeecCCccC-Cccccccc-cccCccccCCCceEecCCCcceeecccCc
Confidence 4799999999999 55444454 887 7778889999888888887765
No 18
>PF11405 Inhibitor_I67: Bromelain inhibitor VI; InterPro: IPR022713 Bromelain inhibitor VI is a double-chain inhibitor consisting of an 11-residue and a 41-residue chain. This protein is the 41-residue heavy chain which is joined to the 11-residue chain by disulphide bonds. The inhibitor acts to inhibit the cysteine proteinase bromelain. ; PDB: 2BI6_H 1BI6_H.
Probab=22.01 E-value=38 Score=20.91 Aligned_cols=16 Identities=44% Similarity=0.985 Sum_probs=6.6
Q ss_pred CCcccccCCCCCCCCC
Q 042006 24 RYRKYCRVGWSDCHGE 39 (119)
Q Consensus 24 ~YGcYCG~GgsGcpg~ 39 (119)
.|-|||---+|.|||-
T Consensus 2 eykcyctdtysdcpgf 17 (41)
T PF11405_consen 2 EYKCYCTDTYSDCPGF 17 (41)
T ss_dssp -SS-EE----SS--TT
T ss_pred cceEEeecccccCchH
Confidence 4789999999999973
Done!